Edinburgh Infectious Diseases Winter Lecture: Wendy Barclay (Imperial College) - Influenza: discoveries and controversies

  • Event:  Annual Edinburgh Infectious Diseases Winter Lecture - Influenza: discoveries and controversies
  • Speaker:  Wendy Barclay (Imperial College; http://www.imperial.ac.uk/people/w.barclay)
  • When:  Thursday 17 November 2016
  • Time:  5.30 - 6.30 pm, followed by drinks reception
  • Location:  Playfair Library, Old College, University of Edinburgh, South Bridge
  • Registration:  Attendance is free, please register at https://winter-lecture-16.eventbrite.co.uk

Meeting with students

Wendy will also be meeting with PhD students and postdocs before the lecture.  She has a wealth of experience in crafting and building an academic career and will be sharing some of her advice and guidance.

The event will be held in G.203 room 2, at Doorway 3 in the Old Medical School, Teviot Place, University of Edinburgh at 3.30 - 4.30 pm on Thursday 17 November, with light refreshments provided.

Numbers are limited, so please sign up at https://coffee-with-wendy.eventbrite.co.uk

More about Wendy

She joined Imperial College in May 2007, moving with her research group from the University of Reading where she had previously been based since 1995.  She graduated in Natural Sciences from Cambridge University and undertook her PhD at the Common Cold Unit, Salisbury under joint supervision of Dr David Tyrrell and Dr Fred Brown, studying the human immune response to rhinovirus.  She acquired molecular virology skills as a postdoctoral fellow first in the laboratories of Professor Jeff Almond at Reading, and then working with Dr Peter Palese at the Mount Sinai School of Medicine, New York.

Her expertise is in the field of respiratory viruses, in particular influenza virus. Her studies aim to understand the molecular and cellular basis of the pathogenesis, host range restrictions and transmissibility of influenza viruses. The approach includes the generation of recombinant viruses with defined mutations. This strategy has contributed to the production of novel influenza pandemic vaccines. In principle the work employs the most appropriate virus strains and relevant cell or animal models. Primary influenza clinical strains are obtained through a long standing collaboration with the Health Protection Agency, and viruses are studied on primary human airway cells and in ferrets.  Translational aspects include analysing mode of action and resistance mechanisms of antiviral compounds, and characterization of novel cell substrates and attenuated virus backbones for influenza vaccines.  The laboratory is funded by MRC, BBSRC, the Wellcome Trust and commercial bodies.

Story tags: 

Please tell us what you think about this website !

What do you think of the Edinburgh Infectious Diseases website?  We would be very grateful if you could spare 2 minutes to help us improve the useability and look of our pages. Thank you for your help !